MAPK8 and rheumatoid arthritis: Han et al. (2019) concluded that CIM could alleviate lipopolysaccharide-induced inflammatory responses in RAW264.7 cells as a rheumatoid arthritis model by inhibiting the phosphorylation of IκB, ERK and p38 (without affecting JNK).